Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IMJX .0004 ImageXpres Expands Sales of LitePix Digital Signage to NYC Region
Jul 26, 2007 10:33:00 AM
ROCHESTER, NY -- (MARKET WIRE) -- 07/26/07 -- ImageXpres Corp (PINKSHEETS: IMJX) today announced that it has entered into a distributor sales agreement with a downstate New York advertising signage company, Message In Motion, LLC, based in Analomink, PA, to market and sell ImageXpres' LitePix Digital Signage products in the NYC region, that includes New Jersey, Philadelphia, PA and Washington, D.C. markets.
Peter Luck, President of Message In Motion, has focused on the bus and rail transportation market segments, and has ongoing sales contracts with several large mass transit companies, such as Martz Bus Lines / Martz Trailways, based in Wilkes-Barre, PA. Message In Motion is reselling LitePix Digital Signs and advertising media, with design, production, and media management services from ImageXpres. A new installation for an exterior LitePix Digital Sign is scheduled for July 30, in Union Station in Washington, D.C. This is a major new market growth opportunity for ImageXpres, in a major upscale market location.
John Zankowski, ImageXpres President and CEO, states, "ImageXpres is pleased to announce our business relationship with Message In Motion, and with it, the Company's ability to enter several major markets for our LitePix Digital Signage, and our iPrint Digital Kiosk products. Peter Luck, President of Message In Motion, will play a significant role in establishing new marketing and sales avenues for ImageXpres products and services in the NYC region. A number of marketing initiatives are underway, that should pave the way for increased sales in the coming months.
"Our LitePix Digital installation in Union Station, Washington, D.C., utilizes a new weatherproof, sunlight-readable LitePix Digital Screen and controller, that enables outdoor digital signage locations, a major growth market dominated by Digital LED Billboard signs to date. If this test application proves successful, ImageXpres can move quickly into exterior digital signage applications, with a lower cost technology solution than LED signage, and extremely large market potential."
About ImageXpres Corporation (PINKSHEETS: IMJX) -- ImageXpres is a digital imaging and printing company, headquartered in Rochester, NY. ImageXpres develops imaging systems solutions for commercial printing, consumer photo, health and business communications market segments. ImageXpres is currently manufacturing and marketing a family of self-service multimedia kiosks, iPrint Digital Photo Kiosks, and LitePix Digital Displays, digital signs that provide unique advertising benefits for business owners. The Company's website is www.imagexpres.com.
About Message In Motion, LLC -- Message In Motion, LLC is an advertising and marketing communications company with a focus on mobile and exterior billboard applications. Message In Motion has a number of exclusive marketing contracts with NYC area bus, trailway and transportation organizations, providing full bus-wrap advertisements for clients in New York City and the Pocono Mountains. The company is expanding into the Washington, D.C. market with traditional as well as digital advertising signage products and services. More information can be found at www.messageinmotion.com.
This press release contains certain "forward-looking" statements, as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, the Company's ability to develop operations, the Company's ability to consummate and complete an acquisition, the Company's access to future capital, the successful integration of acquired companies, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, sales and other factors that may be identified from time to time in the Company's public announcements.
This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.
Contact:
ImageXpres Corp at Signature Leisure, Inc.
Stephen Carnes
407-599-4886
info@signatureleisure.com
morning bob n birdies! heads up PDVP up 80% at .0009 :)
NNRF beauty!
PDVP source = company NR 7/9/2007
AS 500M OS 488,000,000 F 294,478,208 are free trading
PDVP up 80% .0008/.0009
OPX 2.08 Opteum Inc. Announces Sale of Additional Mortgage Servicing Rights
Jul 26, 2007 9:24:00 AM
Copyright Business Wire 2007
VERO BEACH, Fla.--(BUSINESS WIRE)--
Opteum Inc. (NYSE:OPX) ("Opteum" or the "Company"), a real estate investment trust ("REIT"), today announced that its majority-owned subsidiary, Orchid Island TRS, LLC ("OITRS"), has entered into a definitive agreement to sell substantially all of its remaining mortgage servicing portfolio. The aggregate unpaid principal balance of the loans underlying the servicing rights sold was approximately $2.97 billion as of June 30, 2007. The sales proceeds will be used to repay debt that is currently secured by OITRS's mortgage servicing portfolio and for other general corporate purposes. The transaction, which is subject to various closing conditions, is expected to be completed by September 4, 2007. Terms were not disclosed.
About Opteum
Opteum Inc. is a REIT that invests primarily in, but is not limited to, residential mortgage-related securities issued by the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac) and the Government National Mortgage Association (Ginnie Mae). Its objective is to earn returns on the spread between the yield on its assets and its costs, including the interest expense on the funds it borrows.
Statements herein relating to matters that are not historical facts are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned that such forward-looking statements are based on information available at the time and on management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in such forward-looking statements. Important factors that could cause such differences are described in Opteum Inc.'s filings with the Securities and Exchange Commission, including Opteum Inc.'s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q. Opteum Inc. assumes no obligation to update forward-looking statements to reflect subsequent results, changes in assumptions or changes in other factors affecting forward-looking statements.
Source: Opteum Inc.
----------------------------------------------
Opteum Inc.
Robert E. Cauley
Chief Financial Officer
772-231-1400
www.opteum.com
MOVE 3.75 Cell Phones and PDAs Revolutionize How Consumers Find Homes on REALTOR.com
Find Homes Anytime, Anywhere With Free Mobile Real Estate Search Service
Jul 26, 2007 9:03:00 AM
Copyright Business Wire 2007
LOS ANGELES--(BUSINESS WIRE)--
REALTOR.com, the nation's most comprehensive real estate network, just launched the next generation real estate search technology, REALTOR.com Mobile. With a free and easy downloadable application, consumers and REALTORS(R) can now perform searches for real-estate listings from their cell phone or PDA anytime, anywhere.
To begin using REALTOR.com Mobile, house hunters simply take their Windows Mobile enabled cell phone or PDA, go to http://Mobile.Realtor.com, download and install the application and they're ready to begin their search.
"We developed REALTOR.com Mobile because more people are using hand held devices to access information on the road," said REALTOR.com Senior Vice President, Product Development, Joe DeTuno. "Through this new mobile technology, consumers now have current listings with property details at their finger tips whenever they want it."
Instead of cruising neighborhoods or searching ads, consumers can now use REALTOR.com Mobile to search for homes using criteria including city, state or zip codes, price range, as well as number of bedrooms and bathrooms. If a prospective home looks interesting and is close by, a simple touch of the "Contact Details" feature connects the house hunter with the listing agent or broker.
"One of the more exciting elements of REALTOR.com Mobile is the 'Homes Near By' feature," said REALTOR.com President, Errol Samuelson. "If you're walking or driving through a neighborhood and see a 'For Sale' sign, one click of a button delivers a photo with all of the property details right to you. With another quick click, you're connected with the listing agent or broker. There's no waiting or wondering because you have instant results. We think the mobility, immediacy and convenience of REALTOR.com Mobile will revolutionize the way people search for homes."
HOME PAGE FEATURES
Similar to the Web site interface, REALTOR.com Mobile features a user-friendly Home Page with several new search and save options. The Homes Near By search feature expands this locator function by searching for listings that meet the selection criteria within a 10-mile range. The Find a Home search option lets you search listings in a particular city/state combination or zip code, with an additional filter allowing for specifications such as number of beds, number of baths and price range. Favorite listings can be stored in a Saved Items search folders for future reference and comparison. To use the Homes Near By feature, consumers need to be equipped with a GPS-enabled mobile device that runs Window Mobile OS.
MAPPING & DRIVING DIRECTIONS
To help find and view homes or neighborhoods, REALTOR.com Mobile also offers maps and driving directions to each home for sale in the area. Through this feature, house hunters can view the home on a map, get driving directions and plot the most convenient route for multiple homes, creating their own home tour. This feature allows house hunters to save information and access it online or offline. In addition, consumers can save the most commonly used addresses such as home and office, as well as the most commonly viewed listings, to avoid retyping or remembering previous searches.
REALTOR.com Mobile can be used with devices running Windows Mobile 5.0 OS, including HP hw6965, HP hw6925, Palm Treo 700w (or Palm Treo 700wx), AT&T 8525 , Cingular 8125, O2 Xda Stealth and Audiovox XV6700.
ABOUT REALTOR.COM(R)
REALTOR.com(R), "Where the world shops for real estate online(TM)", is operated by Move, Inc., and is the official Web site of the National Association of REALTORS(R). Ranked as the No. 1 homes-for-sale site, REALTOR.com(R) currently offers potential home buyers access to nearly four million property listings as well as the most brokers and agents to contact. The site also provides REALTORS(R) and the home sellers they represent with the Internet's largest real estate marketplace, reaching more than 5.3 consumers in June 2007.(1) Agents and companies have the power to customize the resources of the REALTOR.com(R) Web site to maximize their brand and productivity. The REALTOR.com(R) Web site (www.realtor.com) is operated by Move, Inc. (NASDAQ:MOVE).
REALTOR(R) and REALTOR.com(R) are registered trademarks of the NATIONAL ASSOCIATION OF REALTORS(R). REALTOR(R) is a federally registered collective membership mark, which identifies a real estate professional who is a Member of the NATIONAL ASSOCIATION OF REALTORS(R) and subscribes to its strict Code of Ethics.
This press release may contain forward-looking statements, including information about management's view of Move's future expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Move, its subsidiaries, divisions and concepts to be materially different than those expressed or implied in such statements. These risk factors and others are included from time to time in documents Move files with the Securities and Exchange Commission, including but not limited to, its Form 10-Ks, Form 10-Qs and Form 8-Ks. Other unknown or unpredictable factors also could have material adverse effects on Move's future results. The forward-looking statements included in this press release are made only as of the date hereof. Move cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Move expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
(1) comScore Media Metrix, June 2007
Source: REALTOR.com
----------------------------------------------
Move Inc.
Julie Reynolds
805-557-3080
julie.reynolds@move.com
or
The Rogers Group
Jessica Schmidt
310-552-4177
jschmidt@rogerspr.com
PPHM .74 Peregrine Pharmaceuticals Adds Pharmaceutical Executive as Head of Business Development for Asia and Europe
-Brings Two Decades of Hands-On Global Experience at Leading Firms to Business Development Team-
Jul 26, 2007 9:00:00 AM
TUSTIN, Calif., July 26 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced the appointment of Mary J. Boyd, Ph.D. as head of business development for Asia and Europe. Dr. Boyd has more than 20 years of international pharmaceutical and biotechnology business development experience with large pharmaceutical companies including GlaxoSmithKline, Novartis and Roche. She will focus on identifying potential partners and negotiating agreements for Peregrine's extensive clinical and preclinical assets in Asian and European markets.
"Mary is a significant addition to the Peregrine business development team, which should benefit from her on-the-ground experience in Asian and European markets where she identified and negotiated international contracts for R&D and clinical stage collaborations, as well as intellectual property licenses," said Steven W. King, president and CEO of Peregrine. "We believe that Mary's involvement will reinforce and extend our current activities, helping to increase Peregrine's global visibility and advancing our efforts to form partnerships that leverage our rich preclinical pipeline and multiple ongoing clinical programs."
Dr. Boyd was previously director, Asia, worldwide business development, R&D for GlaxoSmithKline; head of business development and licensing for Japan for Novartis; and head, licensing and patent group for Roche in Japan. In these positions, she identified new opportunities, negotiated global agreements and maintained productive relationships with other companies. Dr. Boyd holds a Ph.D. in Developmental Genetics from the University of Cambridge, UK and a B.Sc in Biochemistry from the University of Sussex, UK.
"Peregrine has a diverse portfolio of novel clinical, preclinical and intellectual property assets available for a variety of collaborative arrangements," said Dr. Boyd. "I look forward to working with Peregrine's management team and drawing on my two decades of experience in Asia and Europe to help the company achieve mutually rewarding relationships with other firms."
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection in the U.S. and India with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.
Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties. It is important to note that the Company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the Company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2007. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
Contacts:
GendeLLindheim BioCom Partners
Investors Media
info@peregrineinc.com Barbara Lindheim
(800) 987-8256 (212) 918-4650
SOURCE Peregrine Pharmaceuticals, Inc.
----------------------------------------------
Investors
1-800-987-8256
info@peregrineinc.com
or Media
Barbara Lindheim
+1-212-918-4650
both of GendeLLindheim BioCom Partners for Peregrine Pharmaceuticals
Inc.
ATML 5.69 Atmel Expands its Board of Directors
Jul 26, 2007 9:00:00 AM
SAN JOSE, Calif., July 26 /PRNewswire-FirstCall/ -- Atmel(R) Corporation (Nasdaq: ATML) today announced the expansion of its Board of Directors from six to eight members with the election of Papken Der Torossian and Jack L. Saltich as new Independent Directors at the Annual Meeting of Stockholders held on July 25, 2007.
Mr. Der Torossian, 68, currently serves as a Director of Parker Vision, the Chairman of Vistec Semiconductor and as Managing Director of Crest Enterprise LLC. Mr. Der Torossian served as Chairman of the Board of Therma Wave, Inc. from 2003 until 2007, when the company was sold to KLA-Tencor. From 1984 to 2001, Mr. Der Torossian was Chairman of the Board and Chief Executive Officer of Silicon Valley Group (SVGI), which was acquired by ASML and started his career with Hewlett Packard where he spent twelve years. Mr. Der Torossian was credited for turning around several companies and operations including as President of ECS Microsystems and President of the Santa Cruz Division of Plantronics, Inc. Mr. Der Torossian also serves as a Director of several privately held companies and was Chairman of the Semiconductor Equipment and Materials International Environmental, Health & Safety Committee (SEMI EHS) and has served as Chairman of Semi/Sematech.
Mr. Saltich, 64, has served as the Chairman and interim Chief Executive Officer of Vitex Systems, Inc., a private technology company, since January 2006. Mr. Saltich also served as the President, Chief Executive Officer and a Director of Three-Five Systems, Inc., a manufacturer of display systems and provider of electronic manufacturing services, from 1999 to 2005. From 1993 to 1999, Mr. Saltich served as Vice President of Advanced Micro Devices and from 1991 to 1993 served as Executive Vice President for Applied Micro Circuits Company. From 1988 to 1991 he was Vice President at VLSI Technology and from 1971 to 1988 served in a number of capacities with Motorola, Inc. Mr. Saltich currently serves as a Director for several public and private companies and is on the Technical Advisory Board of DuPont Electronic Materials and the Manufacturing Advisory Board for Cypress Semiconductor.
"We are pleased to have expanded our Board with the election of Mr. Der Torossian and Mr. Saltich as new Directors," stated Steven Laub, Atmel's President and Chief Executive Officer. "Their industry knowledge and experience will prove invaluable as we identify and pursue new opportunities that drive sustainable long-term growth and increased shareholder value."
About Atmel
Atmel is a worldwide leader in the design and manufacture of microcontrollers, advanced logic, mixed-signal, nonvolatile memory and radio frequency (RF) components. Leveraging one of the industry's broadest intellectual property (IP) technology portfolios, Atmel provides the electronics industry with complete system solutions focused on consumer, industrial, security, communications, computing and automotive markets.
Contact: Robert Pursel, Director of Investor Relations, 408-487-2677
SOURCE Atmel Corporation
----------------------------------------------
Robert Pursel
Director of Investor Relations of Atmel
+1-408-487-2677
TIVO 5.83 TiVo Appoints Karen Bressner as Senior Vice President of Advertising Sales
- Former Viacom Executive to Lead TiVo's Advertising Business -
Jul 26, 2007 9:00:00 AM
ALVISO, Calif., July 26 /PRNewswire-FirstCall/ -- TiVo Inc. (Nasdaq: TIVO), the creator of and a leader in television services for digital video recorders (DVRs), today announced it has appointed Karen Bressner as Senior Vice President of Advertising Sales.
Based in New York and reporting directly to TiVo President and CEO Tom Rogers, Ms. Bressner brings to TiVo more than 25 years of experience in developing strategies for integrated sales efforts across national cable television, broadcast, and online. These efforts have resulted in significant growth in advertising revenue and a substantial increase in the national advertiser base in her prior positions.
Prior to joining TiVo, Ms. Bressner was Senior Vice President, National Advertising Sales for some of Viacom International's most well known brands, running advertising sales for Nick at Nite, TV Land, and TVLAND.com. Prior to that, she served as Vice President, Eastern Region Sales for Discovery Communications, Inc. Ms. Bressner launched her advertising career at Young & Rubicam Inc. and Foote, Cone & Belding. In 2007, Ms. Bressner was named recipient of Working Mother magazine's "Advertising Working Mother of the Year".
"I am very pleased to have Karen on board. I believe that with her experience in leading sales for some of the most well-known brands in the media industry, she will be critical in helping TiVo realize its full potential as the DVR continues to impact television advertising," said Rogers. "The momentum of our advertising assets is enabling us to weave our way into the fabric of the media industry. With the addition of Karen, I am confident that we are poised for strength and growth in our advertising business."
"I am thrilled to join the TiVo team. I was particularly attracted to TiVo's dedication to developing advertising solutions that help advertisers reach consumers who are increasingly fast-forwarding through television advertising," said Bressner. "I look forward to taking part in this burgeoning business, which I believe has great promise for future growth."
About TiVo Inc.
Founded in 1997, TiVo (NASDAQ: TIVO) pioneered a brand new category of products with the development of the first commercially available digital video recorder (DVR). Sold through leading consumer electronic retailers, TiVo has developed a brand which resonates boldly with consumers as providing a superior television experience. Through agreements with leading satellite and cable providers, TiVo also integrates its DVR service features into the set- top boxes of mass distributors. TiVo's DVR functionality and ease of use, with such features as Season Pass(TM) recordings, WishList(R) searches, and TiVo(R) KidZone, have elevated its popularity among consumers and have created a whole new way for viewers to watch television. With a continued investment in its patented technologies, TiVo is revolutionizing the way consumers watch and access home entertainment. Rapidly becoming the focal point of the digital living room, TiVo's DVR is at the center of experiencing new forms of content on the TV, such as broadband delivered video, music and photos. With innovative features, such as TiVoToGo(TM) transfers and online scheduling, TiVo is expanding the notion of consumers experiencing "TiVo, TV your way.(R)" The TiVo(R) service is also at the forefront of providing innovative marketing solutions for the television industry, including a unique platform for advertisers and audience measurement research. The company is based in Alviso, Calif.
TiVo, Season Pass, WishList, Series2, Series3, TiVoToGo, 'TiVo, TV your way' and the TiVo Logo are trademarks or registered trademarks of TiVo Inc. or its subsidiaries worldwide. (C) 2007 TiVo Inc. All rights reserved.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to, among other things, possible future growth in TiVo's advertising business and related revenues. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, "believe," "expect," "may," "will," "intend," "estimate," "continue," or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. Factors that may cause actual results to differ materially include delays in development, competitive service offerings and lack of market acceptance, as well as the other potential factors described under "Risk Factors" in the Company's public reports, including the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2007 and subsequent current and quarterly reports filed with the Securities and Exchange Commission. The Company cautions you not to place undue reliance on forward- looking statements, which reflect an analysis only and speak only as of the date hereof. TiVo disclaims any obligation to update these forward-looking statements.
SOURCE TiVo Inc.
----------------------------------------------
Investor Relations
Derrick Nueman
+1-408-519-9677
dnueman@tivo.com; or Media Relations
Whit Clay of Sloane & Company
+1-212-446-1864
wclay@sloanepr.com
for TiVo Inc.
TRGT 9.14 Targacept Initiates Phase I Clinical Trial of TC-5619
Jul 26, 2007 8:55:00 AM
Copyright Business Wire 2007
WINSTON-SALEM, N.C.--(BUSINESS WIRE)--
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics(TM), today announced that it has initiated a Phase I clinical trial of TC-5619, a novel small molecule that modulates the activity of the neuronal nicotinic receptor (NNR) subtype known as alpha7. TC-5619 was discovered using Targacept's proprietary drug design technology known as Pentad(TM) and is the lead product candidate in its alpha7 NNR program.
"The entry of TC-5619 into the clinic further demonstrates the breadth and pharmacological diversity of our pipeline of NNR Therapeutics," said J. Donald deBethizy, Ph.D., Targacept's President and Chief Executive Officer. "The broad therapeutic application of the alpha7 NNR is well established and presents multiple opportunities for potential later stage development of TC-5619. We are also excited by the promise of other alpha7 compounds in our portfolio."
The Phase I study is designed to evaluate the safety, tolerability and pharmacokinetics of TC-5619. The trial is a double-blind, placebo-controlled study with single escalating doses of TC-5619 administered orally to healthy volunteers.
The alpha7 NNR is associated with a variety of biological functions. In particular, the alpha7 NNR has been shown in animal studies to be an essential regulator of both inflammation arising from injury or infection and cognitive functions. Published in vitro studies have also suggested that the alpha7 NNR plays a role in protecting neuronal cells from deterioration and death, a process known as neuroprotection.
About Targacept
Targacept is a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics(TM), a new class of drugs for the treatment of central nervous system diseases and disorders. Targacept's product candidates selectively modulate neuronal nicotinic receptors that serve as key regulators of the nervous system to promote therapeutic effects and limit adverse side effects. Targacept has product candidates in development for Alzheimer's disease and cognitive deficits in schizophrenia, pain and depression, and multiple preclinical programs. Targacept is located in Winston-Salem, North Carolina. For more information about Targacept, please visit http://www.targacept.com.
Forward-Looking Statements
Any statements in this press release about strategies, prospects, plans, expectations or objectives for Targacept, Inc., including, without limitation, statements regarding the progress, timing and scope of research and development of TC-5619 and related regulatory filings and clinical trials, and all other statements that are not purely historical in nature, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Without limiting the foregoing, the words "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "promise," "continue," "ongoing" and similar expressions are intended to identify forward-looking statements. Actual results may differ materially from those expressed or implied by forward-looking statements as a result of various important factors, including our critical accounting policies and risks and uncertainties relating to: the results of clinical trials and non-clinical studies and assessments with respect to TC-5619 or our other current and future product candidates in development; the conduct of such trials, studies and assessments, including the performance of third parties that we engage to execute them and difficulties or delays in the completion of patient enrollment or data analysis; the timing and success of submission, acceptance and approval of regulatory filings; our ability to obtain substantial additional funding; our ability to establish additional strategic collaborations; and our ability to obtain, maintain and enforce patent and other intellectual property protection for our product candidates and discoveries. These and other risks and uncertainties are described in greater detail under the heading "Risk Factors" in our most recent Annual Report on Form 10-K and in other filings that we make with the Securities and Exchange Commission. As a result of the risks and uncertainties, the results or events indicated by the forward-looking statements may not occur. We caution you not to place undue reliance on any forward-looking statement.
In addition, any forward-looking statements in this release represent our views only as of the date of this release and should not be relied upon as representing our views as of any subsequent date. We anticipate that subsequent events and developments may cause our views to change. Although we may elect to update these forward-looking statements publicly at some point in the future, whether as a result of new information, future events or otherwise, we specifically disclaim any obligation to do so, except as required by applicable law. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.
Source: Targacept, Inc.
----------------------------------------------
Targacept
Inc.
Alan Musso
VP and CFO
336-480-2186
alan.musso@targacept.com
or
For Targacept
Inc.
Linnden Communications
Michelle Linn
508-419-1555
linnmich@comcast.net
WLM 3.27 Wellman, Inc. Sells Its European Fibers Business to an Affiliate of AURELIUS AG
Jul 26, 2007 8:51:00 AM
Copyright Business Wire 2007
FORT MILL, S.C.--(BUSINESS WIRE)--
Wellman, Inc. (NYSE: WLM) announced that it sold its European recycled-based fibers business ("WIL") for approximately $38 million to an affiliate of AURELIUS AG ("AURELIUS"). WIL has the capacity to produce approximately 185 million pounds of polyester fiber primarily using post-consumer recycled materials. The fibers are used in a wide range of applications including personal hygiene, upholstered furniture, loose-filled bed products, car interior trim and industrial uses.
Thomas M. Duff, Wellman's Chairman and Chief Executive Officer, stated, "The sale of this business reflects our strategy to focus on our U.S. chemical-based business."
Dick Budden, Managing Director of WIL, said, "We are pleased with the result of Wellman's investigation of strategic alternatives for our business. With the support of AURELIUS we shall continue providing first class products and service to all our customers, and have the resources to expand our business, both in fibres and in recycled materials for other applications."
Dirk Markus, CEO of AURELIUS, said, "This is an excellent addition to AURELIUS's portfolio and is an attractive investment opportunity which is expected to increase our earnings. Additionally, WIL's manufacturing process uses recycled raw materials, which helps the environment and meets politically and socially important objectives in Europe."
Wellman, Inc. manufactures and markets high-quality polyester products, including PermaClear(R) brand PET (polyethylene terephthalate) packaging resin and Fortrel(R) brand polyester fiber.
AURELIUS AG based in Munich/Germany (www.aureliusinvest.com) acquires mid-sized companies and corporate spin-offs which are no longer part of the core business of the previous owner. AURELIUS increases the value of its investments to the benefit of all parties, using its own specialized project group and selective investment where appropriate, while paying particular attention to its social responsibility. The shares of AURELIUS AG trade under code AR4 (ISIN: DE000A0JK2A8) on the Open Market of the Frankfurt Stock Exchange.
Forward-Looking Statements
Statements contained in this release that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition, words such as "believes," "expects," "anticipates," and similar expressions are intended to identify forward-looking statements. These statements are made as of the date hereof based upon current expectations, and we undertake no obligation to update this information contained herein. These forward-looking statements involve certain risks and uncertainties, including, but not limited to: reduced raw material margins; availability and cost of raw materials; reduced sales volumes; increase in costs; volumes of textile imports; prices and volumes of polyester staple fiber and PET resin imports; the actions of our competitors; the financial condition of our customers; availability of financing, changes in financial markets, interest rates, credit ratings, tax risks; inability to execute our strategy; environmental risks and foreign currency exchange rates; natural disasters; regulatory changes; U.S., European, Asian and global economic conditions; work stoppages; levels of production capacity and profitable operations of assets; prices of competing products; acts of terrorism; and maintaining the operations of our existing production facilities. Actual results may differ materially from those expressed herein. Results of operations in any past period should not be considered indicative of results to be expected in future periods. Fluctuations in operating results may result in fluctuations in the price of our common stock. For a more complete description of the prominent risks and uncertainties inherent in our business, see our Form 10-K for the year ended December 31, 2006.
Source: Wellman, Inc.
----------------------------------------------
Wellman
Inc.
Michael Bermish
803-835-2238
Investor Relations Officer
DVD 5.90 Dover Motorsports, Inc. Reports Results for the Second Quarter
Jul 26, 2007 8:50:00 AM
DOVER, Del., July 26 /PRNewswire-FirstCall/ -- Dover Motorsports, Inc. (NYSE: DVD) today reported its results for the second quarter ended June 30, 2007.
For the quarter ended June 30, 2007 revenues were $40,806,000 compared with $45,003,000 in the second quarter of 2006. Earnings before income taxes were $11,285,000 compared with $15,012,000 in the comparable quarter of the prior year.
The Company promoted seven major events over five weekends in the second quarter of both 2007 and 2006. Adverse weather affected four of the five event weekends in 2007. Dover's Spring NASCAR NEXTEL Cup race was rained out on Sunday for the first time in 32 years. The impact of postponing our June Cup race from Sunday to Monday, together with the previously reported decrease in our television broadcast rights fees under the initial years of NASCAR's new broadcast agreement, adversely affected our results. Decreased revenues from admissions, sponsorship, program sales, concessions and merchandise as well as higher expenses from an extra day's activities resulted in a decrease in profitability. Results from Dover's Spring Friday and Saturday events were not impacted by weather and were comparable to the prior year.
For the quarter ended June 30, 2007 operating and marketing expenses were $23,780,000 compared with $23,272,000 in the comparable quarter of 2006. Higher advertising and promotional activities and the additional cost of operating the Dover facility over a four day weekend contributed to the increase in operating expense. General and administrative expenses of $3,135,000 in the second quarter of 2007 were 1% lower than the $3,173,000 for the same quarter last year.
The income tax provision for the quarter ended June 30, 2007 was $5,692,000 compared with $6,683,000 in the prior year. The effective tax rate for the second quarter was 50.4% in 2007 compared with 44.5% in the prior year. The higher rate in 2007 was due to the impact of a reversal of a tax contingency accrual in 2006 and a decrease in the Company's estimated 2007 annual consolidated pre-tax earnings. The tax rates in both years were affected by state income tax expenses attributable to valuation allowances established on certain state net operating losses.
Net earnings for the quarter ended June 30, 2007 were $5,593,000 or $.16 per diluted share compared with $8,329,000 or $.23 per diluted share for the same period last year. The lower TV broadcast rights fees and the higher effective income tax rate each affected earnings by $.02 per diluted share.
For six months ended June 30, 2007, revenues were $41,688,000 compared with $45,804,000 in the prior year. The Company promoted seven major events in the first half of both years. Net earnings were $2,033,000 or $.06 per diluted share compared with $3,936,000 or $.11 per diluted share in the comparable period of the prior year.
For the first half of 2007 cash provided by operations was $4,801,000 compared with $7,178,000 in the prior year. At June 30, 2007, indebtedness was $49,007,000 compared with $51,204,000 that was outstanding a year earlier.
Capital spending, primarily from the Monster Makeover project, was $8,745,000 in the first half of 2007 compared with $2,038,000 in the prior year. The Company expects capital spending of $1,500,000 to $2,000,000 during the second half of the year.
This release contains or may contain forward-looking statements based on management's beliefs and assumptions. Such statements are subject to various risks and uncertainties which could cause results to vary materially. Please refer to the Company's SEC filings for a discussion of such factors.
Dover Motorsports, Inc. is a leading promoter of motorsports events in the
United States. Its motorsports subsidiaries operate four motorsports tracks
in three states and promote motorsports events under the auspices of three of
the premier sanctioning bodies in motorsports -- NASCAR, IRL, and NHRA. The
Company owns and operates Dover International Speedway in Dover, Delaware;
Nashville Superspeedway near Nashville, Tennessee; Gateway International
Raceway near St. Louis, Missouri; and Memphis Motorsports Park in Memphis,
Tennessee.
DOVER MOTORSPORTS, INC.
CONSOLIDATED STATEMENTS OF EARNINGS
In Thousands, Except Per Share Amounts
(Unaudited)
Three Months Ended Six Months Ended
June 30, June 30,
2007 2006 2007 2006
Revenues:
Admissions $15,760 $16,613 $15,847 $16,698
Event-related 10,494 12,117 11,278 12,807
Broadcasting 14,512 16,244 14,512 16,244
Other 40 29 51 55
40,806 45,003 41,688 45,804
Expenses:
Operating and marketing 23,780 23,272 26,174 25,490
General and administrative 3,135 3,173 6,306 6,192
Depreciation and amortization 1,565 2,397 3,094 4,780
28,480 28,842 35,574 36,462
Operating earnings 12,326 16,161 6,114 9,342
Interest income 32 11 75 23
Interest expense (1,073) (1,160) (2,002) (2,286)
Earnings before income tax expense 11,285 15,012 4,187 7,079
Income tax expense 5,692 6,683 2,154 3,143
Net earnings $5,593 $8,329 $2,033 $3,936
Net earnings per common share:
Basic $0.16 $0.23 $0.06 $0.11
Diluted $0.16 $0.23 $0.06 $0.11
Weighted average shares outstanding:
Basic 35,876 35,999 35,871 36,049
Diluted 35,991 36,198 35,963 36,211
DOVER MOTORSPORTS, INC.
CONSOLIDATED BALANCE SHEETS
In Thousands
(Unaudited)
June 30, June 30, December 31,
2007 2006 2006
ASSETS
Current assets:
Cash and cash equivalents $1,330 $1,249 $298
Accounts receivable 14,766 15,101 2,935
Inventories 334 290 244
Prepaid expenses and other 4,653 4,202 1,808
Receivable from Dover Downs Gaming &
Entertainment, Inc. - - 9
Income taxes receivable 101 158 -
Deferred income taxes 217 495 193
Total current assets 21,401 21,495 5,487
Property and equipment, net 158,187 218,285 152,502
Restricted cash 2,673 2,104 3,684
Other assets, net 1,278 1,346 1,261
Goodwill - 2,487 -
Total assets $183,539 $245,717 $162,934
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $4,065 $2,642 $1,938
Accrued liabilities 4,768 5,549 3,400
Payable to Dover Downs Gaming &
Entertainment, Inc. 38 1 -
Income taxes payable - - 478
Current portion of bonds payable - 695 695
Deferred revenue 19,755 20,058 10,008
Current liabilities of discontinued
operation - 103 -
Total current liabilities 28,626 29,048 16,519
Revolving line of credit 44,800 46,300 39,000
Bonds payable 4,207 4,209 4,211
Liability for pension benefits 664 - 771
Other liabilities - 21 -
Noncurrent income taxes payable 9,296 - -
Deferred income taxes 20,493 50,610 28,173
Total liabilities 108,086 130,188 88,674
Stockholders' equity:
Common stock 1,657 1,637 1,635
Class A common stock 1,967 1,992 1,977
Additional paid-in capital 99,599 100,032 99,412
(Accumulated deficit) retained
earnings (27,126) 12,296 (28,071)
Accumulated other comprehensive loss (644) (428) (693)
Total stockholders' equity 75,453 115,529 74,260
Total liabilities and stockholders'
equity $183,539 $245,717 $162,934
DOVER MOTORSPORTS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
In Thousands
(Unaudited)
Six Months Ended
June 30,
2007 2006
Operating activities:
Net earnings $2,033 $3,936
Adjustments to reconcile net earnings
to net cash provided by operating activities
of continuing operations:
Depreciation and amortization 3,094 4,780
Amortization of credit facility fees 91 97
Stock-based compensation 247 235
Deferred income taxes 1,285 2,061
Changes in assets and liabilities:
Accounts receivable (11,831) (12,735)
Inventories (90) (60)
Prepaid expenses and other (2,949) (2,482)
Income taxes receivable/payable (579) (448)
Accounts payable 2,127 1,165
Accrued liabilities 1,368 128
Payable to/receivable from Dover Downs
Gaming & Entertainment, Inc. 47 (14)
Deferred revenue 9,747 10,536
Other liabilities 211 (21)
Net cash provided by operating
activities of continuing operations 4,801 7,178
Net cash used in operating activities
of discontinued operation - (41)
Investing activities:
Capital expenditures (8,745) (2,038)
Restricted cash 1,011 1,096
Net cash used in investing activities (7,734) (942)
Financing activities:
Borrowings from revolving line of
credit 20,300 17,300
Repayments of revolving line of credit (14,500) (20,100)
Repayments of bonds payable (699) (874)
Dividends paid (1,088) (1,093)
Repurchase of common stock (54) (1,141)
Excess tax benefit on stock awards 6 16
Other - (7)
Net cash provided by (used in)
financing activities 3,965 (5,899)
Net increase in cash and cash
equivalents 1,032 296
Cash and cash equivalents, beginning of
period 298 953
Cash and cash equivalents, end of
period $1,330 $1,249
SOURCE Dover Motorsports, Inc.
----------------------------------------------
Patrick J. Bagley
Sr. Vice President-Finance of Dover Motorsports
Inc.
+1-302-883-6530
DCTH 4.10 Delcath to Present at the ThinkBIG 2007 Conference Sponsored by ThinkEquity Partners LLC
Jul 26, 2007 8:41:00 AM
Copyright Business Wire 2007
STAMFORD, Conn.--(BUSINESS WIRE)--
Delcath Systems, Inc. (Nasdaq:DCTH) today announced that its Chief Executive Officer, Richard L. Taney, will present at the upcoming ThinkBIG 2007 Conference, a gathering of top performing small cap companies sponsored by ThinkEquity Partners LLC for their institutional investor clients. The Delcath presentation is scheduled for 11:15 AM Eastern Time on Thursday, August 2, 2007. The event will be held at the Mandarin Oriental Hotel in New York City.
About Delcath Systems, Inc.
Delcath Systems is the developer of percutaneous perfusion technology for organ- or region-specific delivery of therapeutic and chemotherapeutic agents. The Delcath system is currently being tested with the drug melphalan in a Phase III trial of patients with metastatic ocular and cutaneous melanoma in the liver, and a Phase II trial of patients with primary liver cancers and metastatic tumors in the liver from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. The Company's intellectual property portfolio currently consists of 12 patents on a worldwide basis including the U.S., Europe, Asia and Canada. For more information, please visit the Company's website www.delcath.com.
Source: Delcath Systems, Inc.
----------------------------------------------
Company Contact:
Delcath Systems
Inc.
Richard Taney
203-323-8668
www.delcath.com
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates
Inc.
Anne Marie Fields
212-838-3777
afields@lhai.com
Bruce Voss
310-691-7100
bvoss@lhai.com
www.lhai.com
XOMA 2.42 XOMA Elects Charles J. Fisher, M.D. to Board of Directors
Jul 26, 2007 8:35:00 AM
2007 PrimeNewswire, Inc.
BERKELEY, Calif., July 26, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) today announced the election of Charles J. Fisher, M.D. to its board of directors. Dr. Fisher will replace Arthur Kornberg, M.D., a member of XOMA's board of directors since 1984, who chose not to stand for reelection at the Company's last annual general meeting of shareholders.
"Dr. Fisher is a seasoned industry veteran and a distinguished clinical researcher," commented Jack Castello, chairman of the board of directors, president and chief executive officer of XOMA. "His experience in clinical development, regulatory affairs and commercialization strategy will be particularly important to XOMA's continued effort to grow its pipeline of new product candidates. We look forward to his expert insight and counsel."
"On behalf of the Board of Directors, I also wish to express our gratitude to Dr. Kornberg for his service and dedication to XOMA," Mr. Castello added. "His visionary perspective has benefited the company tremendously through the years."
Charles J. Fisher, M.D. is Chief Medical Officer and Executive Vice President of Clinical and Regulatory Affairs at Cardiome Pharma Corp. He has more than 20 years of leadership experience in clinical research and drug development and, during his earlier academic career, served as Principal Investigator of numerous clinical trials. Prior to Cardiome Pharma Corp., Dr. Fisher was divisional Vice President of Global Pharmaceutical Development at Abbott Laboratories Limited, responsible for the global development of pharmaceuticals, biologics and drug coated medical devices. Prior to Abbott Laboratories Limited, he was an Executive Director and Clinical Research Fellow at Eli Lilly & Co, where he led the scientific team in the development and regulatory approval of Xigris(r) (drotrecogin alfa (activated)) for the treatment of severe sepsis. Dr. Fisher also held professor and director positions at numerous academic institutions before joining industry, including the University of Manitoba, the University of California at Davis Medical Center, Case Western Reserve University and the Cleveland Clinic Foundation where he was Professor and Head of Critical Care Medicine.
Dr. Fisher is a Fellow of the American College of Physicians, American College of Chest Physicians, American College of Critical Care Physicians, American College of Emergency Physicians, and the American Academy of Emergency Medicine. An international thought leader in sepsis, Dr. Fisher has authored 88 peer-reviewed manuscripts and has been a reviewer for 14 journals. He obtained his medical degree from Michigan State University. He completed his internship and residency at the University of California, UC Davis Medical Center and fellowship training at the University of Manitoba.
About XOMA
XOMA is a leader in the discovery, development and manufacture of therapeutic antibodies, with a therapeutic focus that includes cancer and immune diseases. XOMA has royalty interests in RAPTIVA(r) (efalizumab), a monoclonal antibody product marketed worldwide (by Genentech, Inc. and Merck Serono S.A.) to treat moderate-to-severe plaque psoriasis, and LUCENTIS(r) (ranibizumab injection), a monoclonal antibody product marketed worldwide (by Genentech and Novartis AG) to treat neovascular (wet) age-related macular degeneration.
The company has built a premier antibody discovery and development platform that includes access to seven of the leading commercially available antibody phage display libraries and XOMA's proprietary Human Engineering(tm) and bacterial cell expression (BCE) technologies. More than 45 companies have signed BCE licenses. XOMA's development collaborators include Lexicon Pharmaceuticals, Inc., Novartis, Schering-Plough Research Institute and Takeda Pharmaceutical Company Limited. With a fully integrated product development infrastructure, XOMA's product development capabilities extend from preclinical sciences to product launch. For more information, please visit the company's website at www.xoma.com.
Certain statements contained herein that relate to future periods are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions that may not prove accurate. Actual results could differ materially from those anticipated due to certain risks inherent in the biotechnology industry and for companies engaged in the development of new products in a regulated market. These risks, including those related to the results of discovery research and preclinical testing; the timing or results of pending and future clinical trials (including the design and progress of clinical trials; safety and efficacy of the products being tested; action, inaction or delay by the FDA, European or other regulators or their advisory bodies; and analysis or interpretation by, or submission to, these entities or others of scientific data); uncertainties regarding the status of biotechnology patents; uncertainties as to the cost of protecting intellectual property; changes in the status of the existing collaborative and licensing relationships; the ability of collaborators, licensees and other third parties to meet their obligations; market demand for products; scale up and marketing capabilities; competition; international operations; share price volatility; XOMA's financing needs and opportunities and risks associated with XOMA's status as a Bermuda company, are described in more detail in XOMA's most recent annual report on Form 10-K and in other SEC filings. Consider such risks carefully in considering XOMA's prospects.
CONTACT: XOMA Ltd.
Investor Relations and Corporate Communications
Greg Mann
510-204-7270
mann@xoma.com
ICOP 7.86 ICOP to Announce Second Quarter 2007 Results on Monday, August 13, 2007
Management to Host Tele-Conference and Webcast Same Afternoon
Jul 26, 2007 8:30:00 AM
LENEXA, Kan., July 26 /PRNewswire-FirstCall/ -- ICOP Digital, Inc. (Nasdaq: ICOP), an industry-leading company engaged in advancing digital surveillance solutions, today announced that the Company will report its results for the three and six months ended June 30, 2007 on the afternoon of Monday, August 13, 2007.
ICOP will also host a teleconference that same day, beginning at 4:15 PM Eastern, and invites all interested parties to join management in a discussion regarding the Company's financial results, corporate progression and other meaningful developments. The conference call can be accessed via telephone by dialing toll free 1-800-240-2134 or via the web at www.ICOP.com. For those unable to participate at that time, a replay of the web cast will be available for 90 days on http://www.ICOP.com.
About ICOP Digital, Inc.
ICOP Digital, Inc. protects people, assets and profits, providing a Veil of Protection(TM) for our nation's communities with innovative, mission- critical security, surveillance and communication solutions. The Company engineers, manufactures and markets mobile and stationary surveillance products for use in the public and private sectors, and facilitates the delivery of live video to first responders. The ICOP Model 20/20(R), ICOP's flagship product, is the leading digital in-car video recorder system for law enforcement. The ICOP Guardian(TM) is a stationary IP camera that records high quality video images on a local server, and is capable of activation through several triggers. ICOP LIVE(TM) delivers live streaming video to and from first responder vehicles and headquarters, empowering first responders with enhanced situational awareness, helping to optimize the outcome of a crisis. (GSA Contractor)
For more information, please view the following video presentations at http://www.icopdigital.com/why_icop.html and www.ICOP.com/veil.html, or visit www.ICOP.com.
Safe Harbor Statement
This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements. The Company may experience significant fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, our reliance on third-party manufacturers and suppliers, government agency budgetary and political constraints, new or increased competition, changes in market demand, and the performance or reliability of our products. These factors and others could cause operating results to vary significantly from those in prior periods, and those projected in forward-looking statements. Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in certain forms the Company has filed with the Securities and Exchange Commission.
For more information, contact:
Laura E. Owen, President & COO
16801 West 116th Street
Lenexa, KS 66219 USA
Phone: (913) 338-5550
Fax: (913) 312-0264
Lowen@ICOP.com
www.ICOP.com
For Investor Relations:
Elite Financial Communications Group, LLC
Dodi Handy, President and CEO
Phone: (407) 585-1080
ICOP@efcg.net
SOURCE ICOP Digital, Inc.
----------------------------------------------
Laura E. Owen
President & COO
+1-913-338-5550
fax
+1-913-312-0264
Lowen@ICOP.com; or Dodi Handy
President and CEO
Elite Financial Communications Group
LLC
+1-407-585-1080
ICOP@efcg.net
AIRV 7.40 Airvana Successfully Completes Multi-Carrier CDMA2000 1xEV-DO Rev B Call
Technology Will Allow Operators to Gain Experience With 4G-Like Services
Jul 26, 2007 8:30:00 AM
2007 PrimeNewswire, Inc.
CHELMSFORD, Mass., July 26, 2007 (PRIME NEWSWIRE) -- Airvana, Inc., a leading provider of network infrastructure products used by wireless operators to provide mobile broadband services, today announced it has successfully completed a multi-carrier CDMA2000 1xEV-DO Revision B (Rev B) call in its development laboratory, a major step towards commercialization.
"Multi-carrier EV-DO will enable operators to deliver a new generation of bandwidth-hungry applications," said Vedat Eyuboglu, CTO of Airvana. "By leveraging their Rev A hardware investment, operators can start gaining experience with 4G-like services at a fraction of the capital investment required to build 4G networks."
Rev B multi-carrier EV-DO is the natural evolution from Rev A, supporting significantly higher per user throughput by multiplexing traffic across multiple carriers. Such multi-carrier multiplexing delivers a significant reduction in data latency when compared to Rev A systems serving the same users on the same carriers. After a software upgrade to a Rev A radio network, operators can launch services utilizing peak speeds of 9.3 Mbps on the forward link and 5.4 Mbps on the reverse link using three 1.25 MHz-wide carriers. This represents a 3x improvement over Rev A in the actual end user experience, which will significantly improve the end user experience when running rich multimedia applications, such as high definition video streaming and music downloads. Further gains are possible in future, as the Rev B standard supports peak data rates of 14.9 Mbps on the same 3 carriers and 73.5 Mbps by aggregating 15 1.25 MHz carriers within 20 MHz of bandwidth.
Rev B multi-carrier EV-DO is part of the CDMA2000 1xEV-DO Rev B standard, and is fully backward compatible with existing Rev 0 and Rev A devices. Additionally, Rev B multi-carrier EV-DO's benefits are not limited to new multi-carrier devices. By upgrading their Rev A networks to multi-carrier EV-DO, operators will be able to boost the user data speeds for Rev A and Rev 0 users by reducing the overall load on the radio network. Multi-carrier EV-DO is also expected to allow operators to increase the number of Rev A VoIP and push-to-talk users they could serve without affecting the experience of data users.
Airvana expects to begin operator trials of Rev B multi-carrier EV-DO in Q3 2007.
About Airvana
Airvana is a leading provider of network infrastructure products used by wireless operators to provide mobile broadband services. Airvana's software and hardware products enable wireless networks to deliver broadband-quality multimedia services to mobile phones, laptop computers and other mobile devices. These services include Internet access, e-mail, music downloads, video, IP-TV, gaming, push-to-talk and voice-over-IP. Airvana's solutions enable new services and deliver carrier-grade mobility, scalability and reliability with relatively low operating and capital costs.
Worldwide, Airvana's mobile broadband systems are deployed on six continents in 16 major networks by industry-leading service providers who demand high standards of carrier-class performance. Airvana has OEM agreements with Alcatel-Lucent, Nortel Networks, and QUALCOMM.
Airvana is headquartered in Chelmsford, MA, USA. For more information, please visit the company's Web site at http://www.airvana.com
Safe Harbor Statement
Any statements in this press release about future expectations, plans and prospects for Airvana, including statements about expectations related to the company's Rev B multi-carrier EV-DO and the timing of operator trials of Rev B multi-carrier EV-DO constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements contain the words "believes," "anticipates," "plans," "expects," "will" and similar expressions. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the inability to predict the future success or market acceptance of Rev B multi-carrier EV-DO, the highly competitive and rapidly evolving market in which Airvana competes, Airvana's limited operating history, the fluctuation of its past operating results and its reliance on sales through Nortel for a significant portion of its revenues and product and service billings and other factors discussed in Airvana's prospectus filed with the Securities and Exchange Commission on July 20, 2007 pursuant to Rule 424. In addition, the forward-looking statements included in this press release represent Airvana's views as of the date of this press release. Airvana anticipates that subsequent events and developments will cause its views to change. However, while Airvana may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Airvana's views as of any date subsequent to the date of this press release.
CONTACT: Airvana, Inc.
Laura Often
508-887-3796
loften@airvana.com
DANKY .91 Danka Sets First Quarter Financial Results Release Date and Conference Call
Jul 26, 2007 8:30:00 AM
ST. PETERSBURG, FL -- (MARKETWIRE) -- 07/26/07 -- Danka Business Systems PLC (NASDAQ: DANKY) will release its first quarter results prior to market open on Thursday, August 2, 2007 and then host a conference call at 10:00 a.m. ET that day with A.D. Frazier, Chairman and Chief Executive Officer, and Edward K. Quibell, Chief Financial Officer.
To participate in the conference call, please dial in 5-10 minutes before the start of the call and follow the operator's instructions. U.S. and Canada callers please dial (800) 309-1555 and International callers please dial (706) 643-7754. Reference conference ID #10126364 when prompted.
If you are unable to join the call, a replay will be available approximately two hours after the call ends. U.S. and Canada callers may dial (800) 642-1687 and International callers may dial (706) 645-9291. Reference conference ID #10126364 when prompted. This playback will be available through 12:00 a.m. ET on August 9, 2007.
About Danka
Danka delivers value to clients by using its expert technical and professional services to implement effective document information solutions. As one of the leading independent providers of enterprise imaging systems and services, the company enables choice, convenience, and continuity. Danka's vision is to empower customers to benefit fully from the convergence of image and document technologies in a connected environment. This approach will strengthen the company's client relationships and expand its strategic value. For more information, visit Danka's web site at www.danka.com.
Certain statements contained in this press release, including statements related to Danka's future business and financial performance, are forward-looking. Such statements reflect the current views of Danka with respect to future events and are subject to certain risks, uncertainties and assumptions that could cause actual results to differ materially from those reflected in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management's analysis only as of the date they are made.
Danka is a registered trademark and Danka @ the Desktop is a trademark of Danka Business Systems PLC. All other trademarks are the property of their respective owners.
Contacts:
Danka St. Petersburg
Cheley Howes
727-622-2760
The Dilenschneider Group
Robert E. Swadosh
212-922-0900 ext. 132
DVW .82 Covad Extends Line Sharing Agreement with AT&T
Agreement Extended to May 2009; Extends Commercial Terms to Former BellSouth Territory
Jul 26, 2007 8:30:00 AM
Copyright Business Wire 2007
SAN JOSE, Calif.--(BUSINESS WIRE)--
Covad Communications Group Inc., (AMEX:DVW), a leading national provider of integrated voice and data communications, today announced the extension of the term of the commercial line sharing agreement it has with AT&T's local telephone companies (NYSE:T). The extension concluded yesterday guarantees access to AT&T copper and remote-terminal facilities for new Covad line share customers through May 2009. The agreement also provides for commercial access to AT&T copper facilities in the former BellSouth territory, also through May 2009. Covad and AT&T also resolved a number of disputes.
"We are pleased to extend and enhance our line sharing agreement with AT&T," said Charles Hoffman, Covad president and chief executive officer. "This agreement highlights the important relationship Covad has with AT&T, our largest customer."
Line sharing allows Covad to deploy its suite of broadband services on the same line that customers use for their voice phone services.
About Covad
Covad is a leading nationwide provider of integrated voice and data communications. The company offers DSL, Voice Over IP, T1, broadband wireless, Web hosting, managed security, IP and dial-up, and bundled voice and data services directly through Covad's network and through Internet Service Providers, value-added resellers, telecommunications carriers and affinity groups to small and medium-sized businesses and home users. Covad broadband services are currently available across the nation in 44 states and 235 Metropolitan Statistical Areas (MSAs) and can be purchased by more than 57 million homes and businesses, which represent over 50 percent of all US homes and businesses. Corporate headquarters is located at 110 Rio Robles San Jose, CA 95134. Telephone: 1-888-GO-COVAD. Web Site: www.covad.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
The foregoing contains "forward-looking statements" which are based on management's current information and beliefs as well as on a number of assumptions concerning future events made by management. Examples of forward-looking statements include expectations regarding our access to AT&T copper and remote-terminal facilities for new Covad line share customers, which are subject to a number of uncertainties and other factors, many of which are outside Covad's control that could cause actual results to differ materially from such statements. These risk factors include uncertainty in telecommunications regulations, among other risks. For a more detailed description of the risk factors that could cause such a difference, please see Covad's 10-K, 10-Q, 8-K and other filings with the Securities and Exchange Commission. Covad disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This information is presented solely to provide additional information to further understand the results of Covad.
Source: Covad Communications Group Inc.
----------------------------------------------
Covad Communications
Michael Doherty
408-952-7431 (Media)
mdoherty@covad.com
Michael Doherty
408-434-2130 (Investor Relations)
investorrelations@covad.com
or
Pinkston Group
Christian Pinkston
703-574-2137
pinkston@pinkstongroup.com
IAO .42 IA Global Increases Global Hotline Revenue Guidance to $47-55 Million; Announces Change in Year-End
Jul 26, 2007 8:30:00 AM
Copyright Business Wire 2007
SAN FRANCISCO--(BUSINESS WIRE)--
IA Global, Inc. (Amex:IAO) announced today that it would be changing its year-end from December 31 to March 31 effective for the fiscal year ended March 31, 2008. The Company will report its annual results for the fiscal year ending December 31, 2007 and also for the fiscal year ended March 31, 2008.
The company's CEO, Derek Schneideman, said, "We are pursuing a large pipeline of potential acquisition targets and to facilitate consistent year-end reporting, we are changing our year-end to match the March 31 year-end typically used by Asian firms, including Global Hotline, Inc. During the twelve months ended March 31, 2007, Global Hotline recorded revenues of $22 million. We are forecasting Global Hotline revenues for the twelve months ending March 31, 2008 at approximately $47-$55 million, or a 114%-150% increase over the prior year period."
About IA Global, Inc.
IA Global, Inc. ("IA Global") is a strategic holding Company with a dedicated focus on growth through mergers and acquisitions in the Pacific Rim region. Our mission is to identify and invest in business opportunities, apply our skills and resources to grow and enhance the performance of those businesses across all business metrics, and to deliver accelerating shareholder value.
To realize this plan, in fiscal 2007/8 the Company is actively expanding investments in businesses in the consumer, technology, services, and health sectors, sectors with long-term growth prospects in which applying our skills and resources can add significant value to our investments. At the same time, the Company is expanding its reach to encompass the Philippines/ Singapore, India, and China, and the outstanding growth opportunities and synergies these markets present.
In Japan, IA Global is 100% owner of Global Hotline, Inc., an operator of major call centers for telemarketing of telecommunications and insurance products. Since our acquisition of the Global Hotline, Inc. in June 2005, its business has expanded rapidly with the agreement of significant multi-year contracts with major corporations. With these revenues streams in place, revenues in 2007/8 are expected to more than double year on year.
In Australia, the Company has a 36% stake in Australian Secured Financial Limited and its affiliates, Australian Secured Investments Ltd, ADJ Services Pty Ltd. and Auslink Ltd (collectively, "ASFL") which raise funds through the issuance of debentures within Australia and provide short term, secured, real property loans to businesses and investors in Australia.
For further information, contact:
Investor Relations
IA Global, Inc.
101 California Street, Suite 2450
San Francisco, CA 94111
415-946-8828 (t)
415-946-8801 (f)
ir@iaglobalinc.com
www.iaglobalinc.com
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements (within the meaning of Section 27a of the Securities Act of 1933 and Section 21e of the Securities Exchange Act of 1934) regarding us and our business, financial condition, results of operations and prospects. Forward-looking statements in this report reflect the good faith judgment of our management and the statements are based on facts and factors as we currently know them. Forward-looking statements are subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Specifically, the comments concerning the profitability, revenue growth and potential new contracts of Global Hotline, and target sectors and markets are forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements, as a result of either the matters set forth or incorporated in this report generally or certain economic and business factors, some of which may be beyond the control of IA Global. These factors include adverse economic conditions, entry of new and stronger competitors, inadequate capital to support our operations and projections of revenues and profitability for the significant contracts. Readers are urged not to place undue reliance on these forward-looking statements which speak only as of the date of this press release. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of the press release.
Source: IA Global, Inc.
----------------------------------------------
Investor Relations of IA Global
Inc.
415-946-8828
ir@iaglobalinc.com
www.iaglobalinc.com
ADEP 6.10 Adept Signs Agreement With CT Robotics LLC to Expand USA Distribution
CT Robotics Brings 25 Years of Robotics Expertise to Customers in the Northeast
Jul 26, 2007 8:30:00 AM
Copyright Business Wire 2007
LIVERMORE, Calif.--(BUSINESS WIRE)--
Adept Technology, Inc. (NASDAQ:ADEP), the leading provider of intelligent vision-guided robotics and global robotics services, announced that they have signed an agreement with CT Robotics, LLC, to be the exclusive representative for Adept's products in the Northeast U.S.A. The relationship between the companies accelerates Adept's distribution expansion strategy and provides customers in the Northeastern U.S. with 25 years of automation expertise based locally in their region.
Under the terms of the agreement, CT Robotics will be the exclusive representative for Adept products and applications services in the Northeast region of the United States. The alliance extends Adept's global distribution expansion strategy initially implemented in Europe. CT Robotics, LLC will maintain a Technical Robotics Center in the region to perform customer demonstrations and feasibility studies and facilitate implementation of flexible automation programs.
"We are thrilled to have CT Robotics, LLC as Adept's exclusive representative," said John Dulchinos, president and COO of Adept Technology, Inc. "Their wealth of automation experience will provide customers implementing robotic solutions with a solid foundation of expertise to draw on."
About Adept Technology, Inc.
Adept is a global, leading provider of intelligent robotics systems and services that enable customers to achieve precision, speed, quality and productivity in their assembly, handling, packaging, testing and other automated processes. With a comprehensive portfolio of high-performance motion controllers, application development software, vision-guidance technology and high-reliability robot mechanisms, Adept provides specialized, cost-effective robotics systems and services to high-growth markets including Packaged Goods, Life Sciences, Disk Drive/Electronics and Semiconductor; as well as to traditional industrial markets including machine tool automation and automotive components. More information is available at www.adept.com.
All trade names are either trademarks or registered trademarks of their respective holders.
Forward-Looking Statements
This press release may contain certain forward-looking statements including statements regarding growth, revenues, cash, margins, expenses and products that involve a number of risks and uncertainties. The company's actual results could differ materially from those expressed in any of the above forward-looking statements for a variety of reasons, including but not limited to: the company's limited cash resources; its customers' ability to pay invoices in a timely manner; the risk that some of its customers may become insolvent; future economic, competitive and market conditions including those in Europe and Asia and those related to the company's strategic markets; risks of acceptance of the company's new or current products in the marketplace; the financial and operating risks and regulatory requirements associated with the company's international operations; the cyclicality of capital spending of the company's customers and lack of long-term customer contracts; the company's dependence on the continued growth of the intelligent automation market; the company's highly competitive industry; rapid technological change within the intelligent automation industry; the lengthy sales cycles for the company's products; the company's significant fixed costs which are not easily reduced; the risks associated with sole or single sources of supply and lengthy procurement lead times; the risks associated with the seasonality of the company's products; the risks associated with product defects; the potential delays associated with the development and introduction of new products or software releases; the company's ability to sell its products through systems integrators and original equipment manufacturers who may also promote competing products; or risks associated with variations in our gross margins based on factors which are not always in our control.
For a discussion of risk factors relating to Adept's business, see Adept's annual report on Form 10-K for the fiscal year ended June 30, 2006 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2007, including the discussion in Management's Discussion and Analysis of Financial Condition and Results of Operations and Risk Factors contained therein.
Source: Adept Technology, Inc.
----------------------------------------------
Adept Technology
Inc.
Press and Industry Analysts:
Lauren Bucher
Marketing
925-245-3533 (voice)
Fax: 925-960-0452
lauren.bucher@adept.com
ACEL 2.26 Alfacell and US Pharmacia Announce ONCONASE(R) Distribution Agreement for Eastern Europe
Jul 26, 2007 8:30:00 AM
SOMERSET, N.J., July 26 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) and US Pharmacia today announced that Alfacell has entered into a distribution agreement with USP Pharma Spolka Z.O.O. (USP Pharma), an affiliate of US Pharmacia, for the commercialization of ONCONASE(R) (ranpirnase), Alfacell's lead drug candidate, in Eastern Europe. ONCONASE is currently being evaluated as a treatment for unresectable malignant mesothelioma (UMM) in a confirmatory Phase IIIb registration study.
Under the distribution agreement, Alfacell has granted USP Pharma exclusive rights for the marketing, sales and distribution of ONCONASE in Poland, Belarus, Ukraine, Estonia, Latvia and Lithuania for an initial term that extends for 10 years after the first commercial sale in the territory. Additionally, Alfacell and US Pharmacia have entered into a securities purchase agreement pursuant to which US Pharmacia has purchased 533,360 shares of Alfacell's common stock at a price of $2.53 per share. Upon execution of the agreements, Alfacell received total cash payments of $1.5 million, consisting of $100,000 as an up-front signing fee under the distribution agreement and $1.4 million for the purchase of Alfacell common stock under the securities purchase agreement. Alfacell will also be entitled to receive milestone payments based on the achievement of certain regulatory approvals and certain sales goals. In addition, Alfacell will receive a transfer price for product sold as well as a significant double-digit royalty rate on net sales.
Alfacell will be responsible for making regulatory filings with and seeking marketing approval from the European Medicines Agency (EMEA) and the manufacturing and supplying of product. USP Pharma will be responsible for all commercial activities and related costs in the territory.
"We are pleased to announce our second commercial partnership," said Kuslima Shogen, chairman and chief executive officer of Alfacell. "Poland plays an important role in our Phase IIIb clinical program. The agreement with USP Pharma represents the establishment of a key relationship in Poland and the rest of the territory designated under this agreement, where the incidence and prevalence of UMM and other cancers continues to rise, and a significant unmet treatment need exists. With its extensive market knowledge, established commercial capabilities, growing commitment to oncology and successful track record, USP Pharma is the ideal partner to maximize the marketing potential of ONCONASE in this territory."
Katarzyna Kusmierz, chairman of US Pharmacia, said: "We are excited about the opportunity to be part of the team that brings ONCONASE to the world. ONCONASE represents a promising new treatment for UMM, a disease for which there is only one currently approved therapy worldwide. ONCONASE also has significant potential in other cancer indications. As such, we believe ONCONASE should be well-received in our markets."
Shogen added: "Moving forward, Alfacell will continue the dialogue about ONCONASE with potential partners in the United States and other key markets. We remain committed to the transformation of Alfacell into a more fully integrated company with research, clinical and commercial dimensions."
About ONCONASE(R)
ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells while sparing normal cells. ONCONASE triggers apoptosis, the natural death of cells, via multiple molecular mechanisms of action in a manner similar to RNA interference (RNAi).
Alfacell expects to obtain data from its Phase IIIb registration study of ONCONASE in UMM later this year. Earlier in 2007, the FDA granted an orphan- drug designation for ONCONASE for the treatment of UMM. ONCONASE had previously received Fast Track status from FDA for the UMM clinical program. Alfacell is also conducting Phase I/II clinical trials of ONCONASE in non- small cell lung cancer (NSCLC) and other solid tumors.
About US Pharmacia
US Pharmacia markets, sells and distributes over-the-counter drug products in Eastern and Northern Europe, and prescription drug products in Poland with plans to expand into other countries. The company conducts activities in Poland, Ukraine, Lithuania, Russia and Bulgaria, and has U.S. offices in Rockville, Md. For more information, visit www.usp.pl/en.
About Alfacell Corporation
Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. For more information, visit www.alfacell.com.
Safe Harbor
This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainties involved in the outcome of clinical trials for ONCONASE, the company's ability to secure necessary marketing approvals of ONCONASE from regulatory agencies, transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.
Media Contact: Investor Contact:
David Schull or Wendy Lau Andreas Marathovouniotis
Russo Partners Russo Partners
212-845-4271 212-845-4253
david.schull@russopartnersllc.com andreas.marathis@russopartnersllc.com
wendy.lau@russopartnersllc.com
SOURCE Alfacell Corporation
----------------------------------------------
Media
David Schull
david.schull@russopartnersllc.com
Wendy Lau
wendy.lau@russopartnersllc.com
+1-212-845-4271
Investors
Andreas Marathovouniotis
+1-212-845-4253
andreas.marathis@russopartnersllc.com
all of Russo Partners
SONS 7.50 Sonus Networks Provides Financial Information for First Half and Fiscal Year 2007; Comments on Options Review and Nasdaq Listing
Jul 26, 2007 8:30:00 AM
WESTFORD, Mass., July 26 /PRNewswire-FirstCall/ -- Sonus Networks, Inc. (Nasdaq: SONS), a leading supplier of service provider Voice over IP (VoIP) infrastructure solutions, announced today that it is providing preliminary financial results for the first half of 2007 and reaffirmed its non-GAAP operating income objective.
Based on its review to date, the Company expects to report year-over-year revenue growth for the first half of 2007 of 16% - 18%. The Company's performance for the first half of 2007 is principally a reflection of an expected shift in certain operators' capital spending to the second half of the year. The Company also expects to report an order-to-revenue ratio that is slightly below 1 for the second quarter, resulting primarily from a longer than expected approval cycle for a significant initial order from a new customer that is now expected in the second half of the year.
For the full year 2007, the Company continues to expect its business to grow at least in line with the overall market forecasts of 20 - 25% annually. The expected shift in operators' capital spending combined with the scope and complexity of certain large deployments underway is expected to result in revenue conversion for the year that will yield year-over-year revenue growth of 14% - 17% for fiscal 2007. With annual business growth in excess of year- over-year revenue growth, the Company expects to again build its backlog as it exits the year. Additionally, the Company continues to target achieving its long-term non-GAAP operating income objective of 17 - 20% in the fourth quarter of 2007.
The Company will host a conference call on August 7, 2007 to discuss its performance for the second quarter and first half of fiscal 2007.
"While we achieved solid revenue growth during the 1st half of 2007, we are of course disappointed that we did not reach the even greater revenue growth opportunities we have been targeting due to the shift in capital spending patterns of certain operators," said Hassan Ahmed, Chairman and CEO, Sonus Networks. "With deployments at the world's five largest operators, we have a clear view of the undiminished demand in the IP-Voice market combined with how and where it is unfolding. We are very pleased that our compelling solutions and deep experience are being selected as the foundation on which the industry's largest operators are relying for their broad and complex IP- communications networks. These trends and our position in the industry give us confidence in our ability to execute on the growth opportunities in the market."
Stock Option Review Update
As previously reported, in August 2006, the Company and its Audit Committee commenced a voluntary review of the Company's stock option granting practices and related accounting. In November 2006, the Company announced that its Audit Committee had completed the voluntary review of the Company's historical stock option granting practices with respect to options granted since its initial public offering in May 2000. The investigation included the collection of over 220 gigabytes of electronic data, a review of more than 2.5 million documents, interviews of numerous current and former directors, officers and employees of the Company and a comprehensive assessment of all of the approximately 5,100 stock option grants issued since the Company's initial public offering. The review was conducted by outside counsel and forensic accountants under the supervision of the Audit Committee and with the full support and cooperation of the Company's current management and personnel.
Based on its analysis to date, the Company anticipates that it will record additional, cumulative, non-cash, stock-based compensation expense for the periods of 2000 through 2005. Additionally, the Company also expects to record tax adjustments related to the stock option review and other previously unrecorded adjustments previously determined to be immaterial.
As the Company previously announced, the review identified no improper conduct or violation of Company policies by any member of the Company's current management.
NASDAQ Listing Update
Sonus also reported today that the Nasdaq Board of Directors has granted the Company until September 17, 2007 to file all delinquent SEC periodic reports necessary to regain compliance with the requirements for continued listing on the NASDAQ Global Select Market.
The Company continues to work diligently to file its Quarterly Reports on Form 10-Q for each of the quarters ended June 30, 2006, September 30, 2006 and March 31, 2007 and its Annual Report on Form 10-K for the year ended December 31, 2006 as soon as possible and expects to file these reports prior to the September 17, 2007 deadline. With these filings, Sonus believes that it will regain compliance with the requirements for continued listing.
About Sonus Networks
Sonus Networks, Inc. is a leading provider of voice over IP (VoIP) infrastructure solutions for wireline and wireless service providers. With its comprehensive IP Multimedia Subsystem (IMS) solution, Sonus addresses the full range of carrier applications, including residential and business voice services, wireless voice and multimedia, trunking and tandem switching, carrier interconnection and enhanced services. Sonus' voice infrastructure solutions are deployed in service provider networks worldwide. Founded in 1997, Sonus is headquartered in Westford, Massachusetts. Additional information on Sonus is available at http://www.sonusnet.com.
This release contains forward-looking statements regarding future events, including the Company's 2007 financial results, that involve risks and uncertainties. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results. Readers are referred to Item 1A "Risk Factors" of Sonus' Quarterly Report on Form 10-Q for the period ended March 31, 2006, filed with the SEC, which identifies important risk factors that could cause actual results to differ from those contained in the forward-looking statements. Risk factors include among others: the impact of material weaknesses in our disclosure controls and procedures and our internal control over financial reporting on our ability to report our financial results timely and accurately; the unpredictability of our quarterly financial results; risks and uncertainties associated with the Company's restatement of its historical stock option granting practices and accounting including regulatory actions or litigation; whether the Company will remain listed on the NASDAQ Global Select Market; risks associated with our international expansion and growth; consolidation in the telecommunications industry; and potential costs resulting from pending securities litigation against the Company. Any forward-looking statements represent Sonus' views only as of today and should not be relied upon as representing Sonus' views as of any subsequent date. While Sonus may elect to update forward-looking statements at some point, Sonus specifically disclaims any obligation to do so.
Sonus is a registered trademark of Sonus Networks, Inc. All other company and product names may be trademarks of the respective companies with which they are associated.
For more information, please contact:
Investor Relations: Sonus Media Relations:
Jocelyn Philbrook Sarah McAuley
978-614-8672 978-614-8745
jphilbrook@sonusnet.com smcauley@sonusnet.com
SOURCE Sonus Networks, Inc.
----------------------------------------------
Jocelyn Philbrook
+1-978-614-8672
jphilbrook@sonusnet.com
or Sarah McAuley
+1-978-614-8745
smcauley@sonusnet.com
both of Sonus Networks
Inc.
MACE 2.55 Mace Signs Exclusive Agreement to Market Proprietary Less-Than-Lethal Aerosol Gun for Its Patented Pepper Gel and Pepper Spray Formulations
Jul 26, 2007 8:35:00 AM
Copyright Business Wire 2007
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--
Mace Security International, Inc. ("Mace" or the "Company") (Nasdaq Global:MACE) today announced that it has signed an exclusive agreement for the distribution of a unique less-than-lethal aerosol pepper gun produced by DragonFire OC Corporation. The professional grade metal encased pepper gun will be marketed under the famous brand name Mace(R), and utilizes patented features and proprietary technology. The less-than-lethal Mace(R) Pepper Gun will be marketed through the Company's recently acquired online direct response marketing and e-commerce platform, as well as through its traditional distribution outlets including mass merchants, guns shops, sporting goods stores and direct mail catalogs, to name a few. Mace also intends to introduce this product to law enforcement.
The less-than-lethal Mace(R) Pepper Gun, which is the first of its kind, will be used with gel or a streaming spray. This product delivers a stream of pepper spray or gel at extended distances up to 30 feet. The gun has unique operational features including a light (that in darkness illuminates the area and interferes with the assailant's ability to see), a manual safety switch and a well-designed ergonomic appearance. The Company's suggested retail price of the product will be $89.95, which includes one replaceable cartridge (pepper spray or gel), one practice cartridge (water) and batteries for the illuminating light. Replaceable and practice cartridges will also be sold separately. Each replaceable cartridge has approximately 20 bursts.
Mace Security International, Inc. is a manufacturer of electronic surveillance, security and personal defense products, and an owner and operator of car and truck wash facilities. Additional information about Mace is available at www.mace.com.
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Federal Private Securities Litigation Reform Act of 1995. When used in this press release, the words or phrases "will likely result", "are expected to", "will continue", "is anticipated", "estimate", "projected", "intend to" or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, including but not limited to economic conditions, dependence on management, dilution to shareholders, limited capital resources, the effects of weather on the demand for car care services, the effects of rapid growth on Mace and the ability of management to effectively respond to that growth, our ability to achieve operating synergies, our ability to compete against established competitors, regulatory matters, the effects of competition, our ability to obtain additional financing and the ability to successfully integrate Linkstar, the ability of Linkstar's management to leverage Mace's offline logistics expertise and its ability to complete the development and secure market acceptance of new proprietary products. Such factors could materially adversely affect Mace's financial performance and could cause Mace's actual results for future periods to differ materially from any opinions or statements expressed within this press release. Additional discussion of factors that could cause actual results to differ materially from management's projections, forecasts, estimates and expectations are contained under the heading "Risk Factors" in Mace's SEC filings, including its registration statements and its periodic reports on Form 10-K and Form 10-Q. This press release should be read in conjunction with the financial statements and notes contained in Mace's annual reports on Form 10-K and quarterly reports on Form 10-Q.
Source: Mace Security International, Inc.
----------------------------------------------
Mace Security International
Inc.
Eduardo Nieves
Jr.
Vice President
Marketing & Investor Relations
954-449-1313
www.mace.com
Ambassador Thomas Graham, Jr., takes the position of Executive Chairman of the Board of Directors, effective on August 1, 2007.
(from june 19, 2007 company NR)
Ambassador Graham is one of the world's leading experts on nuclear non-proliferation. As a senior U.S. diplomat, he was involved in the negotiation of every major international arms control and non-proliferation agreement leading up to the end of the Cold War and permanent extension in force of the Nuclear Non-Proliferation Treaty (NPT). Ambassador Graham played a leading role in negotiation of the Strategic Arms Limitations Talks (SALT Treaties), the Strategic Arms Reduction Talks (START), Comprehensive Test Ban Treaty (CTBT) and many others.
A lawyer by training, Ambassador Graham served for 15 years as the general counsel of the U.S. Arms Control and Disarmament Agency (ACDA). He also served as the Special Representative of the President of the United States for Arms Control, Non-Proliferation, and Disarmament from 1994 through 1997, where he successfully led U.S. government efforts to achieve the permanent extension of the Nuclear Non-Proliferation Treaty with the consensus of all parties to the treaty, which were essentially every country in the world except for three countries that were not parties. As part of this process, Ambassador Graham met with representatives of about 180 countries and traveled to over seventy of those countries for negotiations. He brings these relationships and an unmatched global perspective to Thorium Power.
Ambassador Graham stated, "I am pleased to play an increasing role in Thorium Power's important business of deploying thorium-based nuclear fuel in the world's reactors. Non-proliferation, the environment, and energy are three of the most important issues facing the world and the global population at large. Given the large number of countries entering the market for nuclear power plants for the first time, I feel that diplomatic efforts to stop the spread of nuclear weapons-usable materials must be supplemented with changes to the nuclear fuel technology. Thorium Power's nuclear fuel-based technology stops the reactors from producing nuclear weapons-usable materials, produces much lower waste, reduces total fuel costs, and can be deployed in both new and existing nuclear reactors. Moreover, our technology has now been successfully demonstrated in a Russian research reactor for over four years. I look forward to utilizing my knowledge of nuclear non-proliferation and my strong relationships with key influencers in the business and political arenas to help commercialize thorium power's nuclear technology."
About Thorium Power, Ltd.
Based in McLean, VA, Thorium Power, Ltd. is a nuclear energy pioneer and the leading provider of low-waste, non-proliferative nuclear fuel technology for existing and future reactors. The Company's technologies include nuclear fuel designs optimized to address key concerns about traditional nuclear power, including nuclear proliferation and nuclear waste. Thorium Power plans to license its technologies to commercial and government owned reactor operators and nuclear fuel fabricators aiming to benefit from thorium-based fuels. The Company is targeting new reactors in countries without a nuclear industry today, as well as currently operating and new reactors in countries with an established industry. Thorium Power is also leveraging its nuclear technology, business and regulatory expertise and relationships by offering services to commercial entities and governments looking to establish or expand nuclear industry capabilities and infrastructure. In addition to leveraging its International and Technical Advisory Boards comprised of key national and international leaders in the fields of nuclear energy, finance, government affairs, non-proliferation and diplomacy, the Company maintains long-standing relationships with leading Russian nuclear entities, providing expert resources and facilities for its nuclear fuel development activities. To support the implementation of its business model, Thorium Power has plans to form partnerships with various types of participants in the nuclear industry, allowing the Company to address multiple nuclear reactor types internationally.
7/26/2007 UWNK 1-4 R/S ** uWink, Inc. Common Stock UWKI uWink, Inc. (Del) Common Stock
7/26/2007 UWNK 1-4 R/S ** uWink, Inc. Common Stock UWKI uWink, Inc. (Del) Common Stock
7/26/2007 RDOC 1-10 R/S ** Integrated Surgical Systems, Inc. Common Stock ISSM Integrated Surgical Systems, Inc. New Common Stock
7/26/2007 ODLG 1-10 R/S ** Order Logistics, Inc. Common Stock ODLO Order Logistics, Inc. New Common Stock
7/26/2007 UWNK 1-4 R/S ** uWink, Inc. Common Stock UWKI uWink, Inc. (Del) Common Stock
a very good company...no pump n dump
green today, thanks! :)
THPW up 11% .29 on above avg vol
hmmm...vol and pps up :)
IFSL very nice!
NEOM up 15% on low vol .03
SHTP .38 QualityStocks News - ShotPak Airs on NBC's Today Show
Jul 25, 2007 10:49:00 AM
Copyright Business Wire 2007
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--
ShotPak (SHTP.PK) announces that their product line of premium distilled spirits and premium vodka flavored mixed cocktails were featured on NBC's Today Show in a segment titled "Five Things You Need To Know about Summer Beverages." The show aired mid-morning today and a clip of the segment will be posted on ShotPak's website before the end of the week for viewing by customers and shareholders.
Today, usually referred to as The Today Show, is an American morning news and talk show airing weekday mornings on the NBC television network, and is the second-longest running American television series. Today has been the highest-rated morning news and talk show in the United States since the week of December 11, 1995.
Ignus Hattingh, CEO and Founder of ShotPak Inc., stated, "NBC's Today Show is providing us with a national platform to enlighten the public to a product that adds value to any lifestyle. We are proud to be on such a quality show and the timing is great because we are in the middle of a national rollout, of our newly packaged products."
Information on ShotPak, Inc.:
ShotPak, Inc., an Irvine, California-based company, since 2003, is a leading distiller and innovator of cocktails and straight spirits in patented soft portable single serving standup pouches. With over 50 years of combined experience and expertise in alcohol distilling, distribution and field marketing, retail placement and promotion as well as consumer trial and adoption, they prove to be a forerunner in the single serve Ready to Drink (RTD) alcohol category. With the successful launch of four premium vodka flavored drinks and four premium distilled spirits in January 2007, ShotPak has instantaneously captured national attention in the rapidly emerging $110 billion plus alcohol beverage industry, with distilled spirits showing an 8.1% increase. They are recognized for being visionaries with their award-winning spirits and revolutionary packaging which gives consumers a cost effective way to purchase spirits without the bulky bottle.
ShotPak products are packaged in single serving, lightweight, break-resistant, recyclable plastic pouches with a built-in spout making it easy to pour anywhere. ShotPak products are ideal for camping, boating, golfing, concerts, sporting events, or for anyone on-the-go. Made with recyclable plastic instead of glass, ShotPak products provide a safe alternative especially during summer activities. ShotPak, Inc. is immersed in a national roll-out through strategic distribution channels and is expected to be available in most major markets this year.
For more information about ShotPak, Inc. please visit us at: www.shotpakinc.com
http://www.QualityStocks.net/Clients.php?clientid=shtp
ShotPak Blog http://Blog.QualityStocks.net/?cat=82
ShotPak Message Board
http://www.QualityStocks.net/MessageBoard/viewtopic.php?t=178
Safe Harbor: Except for the historical information contained herein, the matters set forth in this press release, including the description of the company and its product offerings, are forward-looking statements within the meaning of the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the historical volatility and low trading volume of our stock, the risk and uncertainties inherent in the early stages of growth companies, the company's need to raise substantial additional capital to proceed with its business, risks associated with competitors, and other risks detailed from time to time in the company's most recent filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements.
Source: QualityStocks.net
----------------------------------------------
QualityStocks
Michael McCarthy
480-308-0703
http://www.QualityStocks.net
editor@QualityStocks.net
QualityStocks News - ShotPak Airs on NBC's Today Show
Jul 25, 2007 10:49:00 AM
Copyright Business Wire 2007
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--
ShotPak (SHTP.PK) announces that their product line of premium distilled spirits and premium vodka flavored mixed cocktails were featured on NBC's Today Show in a segment titled "Five Things You Need To Know about Summer Beverages." The show aired mid-morning today and a clip of the segment will be posted on ShotPak's website before the end of the week for viewing by customers and shareholders.
Today, usually referred to as The Today Show, is an American morning news and talk show airing weekday mornings on the NBC television network, and is the second-longest running American television series. Today has been the highest-rated morning news and talk show in the United States since the week of December 11, 1995.
Ignus Hattingh, CEO and Founder of ShotPak Inc., stated, "NBC's Today Show is providing us with a national platform to enlighten the public to a product that adds value to any lifestyle. We are proud to be on such a quality show and the timing is great because we are in the middle of a national rollout, of our newly packaged products."
Information on ShotPak, Inc.:
ShotPak, Inc., an Irvine, California-based company, since 2003, is a leading distiller and innovator of cocktails and straight spirits in patented soft portable single serving standup pouches. With over 50 years of combined experience and expertise in alcohol distilling, distribution and field marketing, retail placement and promotion as well as consumer trial and adoption, they prove to be a forerunner in the single serve Ready to Drink (RTD) alcohol category. With the successful launch of four premium vodka flavored drinks and four premium distilled spirits in January 2007, ShotPak has instantaneously captured national attention in the rapidly emerging $110 billion plus alcohol beverage industry, with distilled spirits showing an 8.1% increase. They are recognized for being visionaries with their award-winning spirits and revolutionary packaging which gives consumers a cost effective way to purchase spirits without the bulky bottle.
ShotPak products are packaged in single serving, lightweight, break-resistant, recyclable plastic pouches with a built-in spout making it easy to pour anywhere. ShotPak products are ideal for camping, boating, golfing, concerts, sporting events, or for anyone on-the-go. Made with recyclable plastic instead of glass, ShotPak products provide a safe alternative especially during summer activities. ShotPak, Inc. is immersed in a national roll-out through strategic distribution channels and is expected to be available in most major markets this year.
For more information about ShotPak, Inc. please visit us at: www.shotpakinc.com
http://www.QualityStocks.net/Clients.php?clientid=shtp
ShotPak Blog http://Blog.QualityStocks.net/?cat=82
ShotPak Message Board
http://www.QualityStocks.net/MessageBoard/viewtopic.php?t=178
Safe Harbor: Except for the historical information contained herein, the matters set forth in this press release, including the description of the company and its product offerings, are forward-looking statements within the meaning of the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the historical volatility and low trading volume of our stock, the risk and uncertainties inherent in the early stages of growth companies, the company's need to raise substantial additional capital to proceed with its business, risks associated with competitors, and other risks detailed from time to time in the company's most recent filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements.
Source: QualityStocks.net
----------------------------------------------
QualityStocks
Michael McCarthy
480-308-0703
http://www.QualityStocks.net
editor@QualityStocks.net
MHUI .004 MicroHoldings US, Inc. Releases Second Quarter Financials for XchangeTel Subsidiary
Jul 25, 2007 9:48:00 AM
Copyright Business Wire 2007
SAN DIEGO--(BUSINESS WIRE)--
MicroHoldings US, Inc. (Pinksheets:MHUI) today released second quarter 2007 financial information for its subsidiary XchangeTel, Inc. (Xtel). For the period of April 1, 2007 to June 30, 2007, Xtel produced $676,696 in gross revenues and had gross profits of $78,056. These gross revenues numbers represent an increase of more than 38% over the first quarter results of $491,000. These financials were not audited by an independent auditing firm.
XchangeTel was acquired by MHUI on March 31, 2007 and with the German based subsidiary, GDS Global Destination Services, is one of the two wholly owned subsidiaries dedicated to providing carrier and telecommunications services.
Stated Joseph Putegnat, Director of Operations for XchangeTel, "Our growth has been solid the last several months and we expect to continue to improve in the months to come. Our ability to work closely with our sister company, GDS, in Germany should also result in increased revenues numbers for the company."
More information on the MicroHoldings US, Inc. can be found at www.microholdings-us.com.
Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of MHUI are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future MHUI actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and MHUI has no specific intention to update these statements.
Source: MicroHoldings US, Inc.
----------------------------------------------
MicroHoldings US
Inc.
Jeffrey Flannery
619-342-8096
ICBM .0018/.002 1x1